Get started

Smallcaps

Triad- 10% jump on Friday with plenty more to come.Triad is inside and up on monthly and weekly timeframes, and in full timeframe continuity to the upside. This company has excellent fundamentals including a large amount of cash equal to over 30% of its current valuation. Currently hugely undervalued due to some legal complications- a former board member taking the company to court- however with the high court ruling in the company's favour and a 10% jump in price on friday after a multi month period of consolidation, there is a good chance a more realistic price will now be found.
LSE:TRDLong
by chrisatom
$LRSV To Go Current. Now Fully Integrated in the Pet CBD MarketThe company has stated that they will be fully current within the next 10 business days. The company has been posting CBD and marijuana oriented tweets and with their brand new website stating; “LinkResPet, a subsidiary of Link Reservations Inc, Produces a line of CBD products specifically tailored for cats, dogs and horses.” The website can be viewed here: www.linkrespet.com . The chart shows that the William volume accumulation indicator points bullish, volume price trend points bullish and the MACD is also bullish making this a great chart play and potential RM play in our opinion.
OTC:LRSVLong
by StockGuild
All the way to Resistance? & Inarguable FundamentalsGuess myself and a very few group of others had underestimated the amount of faith in this market. I had wholeheartedly felt we would see the Dow cut short of the move towards the resistance line set by the other 3 peaks preceding. Though I had left room to suggest the possibility of this happening, I did have doubts and I did voice those doubts with others, so I was wrong, and I owe gratitude to my counter parts for being fair enough with me to reasonably say, “well, maybe”. That said, the long term perspective still reads the same. The fundamentals are still shallowing up, and the technicals, when compared to previous end-cycles have very distinctly similar patterns, if we are to truly push back from this point of resistance and engage in a massive sell off shortly after. This time, I’d like to be a little more open and take a position that we will test the resistance line at least once more on the way day. And this is not for the sake of holding weight to the recent news on positive earnings, as anyone that truly invests knows that these earnings were only “solid” because they came close to juncture with the wall st estimates. If we remember, however, those earnings estimates were revised downward from previous quarters, so it means nothing that we met the expectations of a market still slowing down fundamentally. A greater crisis that I think is looming still goes back not large-cap corporate debt but the debt on personal financing, consumers and credit cards. Those are all at records. Coupling that with the Fed Reserve’s charts depicting the total money supply in “deposit accounts”, we see that those accounts are dwindling pretty hard. This loss of deposit away from the market correlated fairly when when regressed to debt repayment expectations. So, liquidity leaving the market is always negative news for future earnings. That said, one other concern I have is with the small-cap companies. Very poor earnings growth for just under half of them, and they are more leveraged in this hour than in any point in time in the index history. I can foresee a lot of negativity in the Russell 2000. Lower earnings make it harder to find coverage on interest payments, and should anyone need to survive by refinancing, they will be doing so at markedly higher interest rates when compared to 2013-2016.
DJ:DJIShort
by thehoplite
Expecting RUT to find support around 1225I believe there will some additional selling before we can see the Rusell find some support around 1220 - 1230 which matches with a 38% retracement from the highs we saw just a couple of months ago, additionally that area matches with the uptrend that started at the end of the financial crisis in Feb 2009. If that long term trend breaks I think we could see it go down all the way to the 2016 lows before it starts moving up again. We might be seeing a bunch of sideways and down movement as we head towards 2019. Happy Holidays :D
TVC:RUT
by the_no_factor
$SL1 down trend breakSL1 has remained in down trend since the 4.2c high in July but is now showing signs of a return to strength. Mid September volume reached an all time low around the base established at 1.8c, since this low the volume has stepped back in lifting the SP to the first resistance point at around 2.5c where significant volume has remained. The next resistance point in this case becomes the target at 3.5c This target is supported by underlying fundamental changes in the company which has recently transitioned to a miner with targeted first shipment of zinc early in the October quarter. The second catalyst in support of growth is the highlighted tenement acquisition by the end of December this year. My initial target is 3.5c which represents a 52% increase from the last traded price, stops set at 1.8c which is the all time low representing a favorable risk to reward ratio of 2.4
SLong
by Michaeljob
EKSO - Buy and hold for future exoskeleton growthI have been wanting to get long-term invested in the stocks that I think will greatly benefit from future technology trends. I believe that pure robotics are further in the future than most people realize, but wearable robotics are much closer to adoption. With that opinion I want to be positioning myself in the exoskeleton market. There are a number of very small exoskeleton companies but the one that stands out me the most is EKSO. A few things that stand out are that they are not only penetrating the medical market but they are also heavily focused on the industrial market, where as the other exoskeleton companies are primarily focused on the medical market. Ekso has also recently landed a few contracts, one with the VA and another with Ford that will help them generate the revenue they need to become profitable. As with most small growth companies the biggest risk here is that they are not yet profitable and will need to generate cash flow through debt or stock dilution, which makes it very important to not jump in too earlier. Up until now it has been too early to buy and hold but I believe with the Ford and VA contracts they may be a few quarters from turning the corner and becoming profitable. Price is still a little rich at this point but I will be looking to buy a little bit around $2.20 - $2.00 as a long term speculative buy-and-hold.
NASDAQ:EKSOLong
by krugman87
TRD- move up expectedTRD has been in an rising channel for 6 years. The high of Dec 16/Jan 17 touched the top of the channel and resulted in a pull back and consolidation of 18 months. Price has reacted to the channel and formed a rounded bottom/cup. Likely outcomes are to form a 'handle' for the cup, or for price to move straight up, targeting the upper channel boundary. The fundamentals of this company are excellent, particularly the amount of cash they have in comparison to their market cap. A break of the lower channel boundary would be very bearish.
LSE:TRDLong
by chrisatom
Small Pharma Big Backers and Partners - LONG SNG (Synairgen)Prudent Drug Discovery Company Low market cap ( appox £13m at time of writing ). Issues shares very rarely ( last placing nearly four years ago ). Has material interest in its work from larger partners ( Pharmaxis ). Sold interest in LOXL2 programme for £5m to Pharmaxis in December. Pharmaxis continues to fund and develop LOXL2 inhibitors and Synairgen retains interest across all fibrotic indications at circa 17% of all partnering proceeds. Potential of drug appears across multiple uses now ( not just lung-related ) and indications from Pharmaxis looking very good. Recent interviews from Pharmaxis management suggest a good chance of a deal with major pharma in H2. Low free float in the stock ( 60% in hands of major shareholders ). Major funds holding ( Woodford Investment Management and Lansdowne Partners ). High profile investors holding stakes ( Richard Griffiths and Leonard Licht ). These high profile investors have been raising, rather than reducing their stakes in the company, periodically. For a risky smallcap biotech stock it appears well placed to survive and thrive, regardless of the short term success of a sale/licencing deal of LOXL2 by Pharmaxis, making it considerably less risky than most biotech stocks in the long term. However, the indications and noises being made about LOXL2 by Pharmaxis are looking as positive as you could hope for, and backed up by them putting their money where their mouth is in the first place and increasing their stake for cash.
LSE:SNGLong
by richthenewbie
3
MITH/KRW Big upside potential.Looks like Mithril is moving back into bullish mode breaking the mid term resistance and setting higher highs and lower lows in the short term. Drew a coupe line to illustrate what I believe is called a rising wedge. I'm new to this so any help is appreciated. I entered Mithril back when it listed on Bithumb around April 16th, price in USD was $0.67. Rode the bull trend up and sold after the first correction down to the $1 area and after the subsequent relief push back up. All in all made about 80% return on the trade. After price created it's new bottom around $0.50 and getting a pretty strong rejection decided it was a good time to get back in. Entering into the trade today at around $0.59. As far as psychologically influences, the company is strong and is currently accepted in a brick and mortar chain in South Korea, they have a live app called "Lit" which is basically a S Korean Snapchat, I use it daily because that's how new coins are mined. Their way of mining is through a process they coined as "Social Mining". Basically the more you post and the more likes you get the more mithril you get. I believe this mechanic is pretty ingenious because the more people use, it the more they make, and the more people that know about it. Add to the fact that anyone can use it to buy real tangible things already, albeit in a limited capacity. But considering it just hit exchanges in March, id say the growth potential here is pretty significant. And I imagine this next wave will be one for the books. Any criticism is appreciated, thanks.
MLong
by Silvertoe
3
[IWM] Small Caps Leading In Potentially Huge Breakout!Same pattern here that I covered in MSFT, CSCO, and ADBE. All are still consolidating at the breakout level, except for ADBE and IWM. IWM is soaring higher today after finishing a short consolidation period at the breakout level of around $160. I put some Fibonacci lines to show how it bounced strongly off the top of wave 1 around $158.15. Since that low on this morning of 5/16, it's rocketed up past $160 and is hovering around $161 !! Bullish sign for the S&P 500 as well as Nasdaq 100. IWM has shown enough strength through this 4-5 month correction to lead in any major moves and as long as it it can maintain above $160 for a good amount of time, the other indices, as well as the other Triangle Breakout Pattern setups i've charted in Tech stocks, should be gearing up for more upside.
AMEX:IWMLong
by NYFinancials
$LMFA OThe Technicals - A clear divergence of the OBV and Price Action , which preludes growing buyer volume and long position sentiment. Earlier last week, $LMFA hit all time-lows with its bottom at 5 cents above the half dollar. Although we have a considerable amount of selling to break past, I would anticipate the larger corrective retest to occur at the 1.414/1.618 extension, throw some impulse/corrective waves on that bad boy and leg it up. The Fundamentals - Domestic based capital financing/lending company serving the nonprofit sector - overall a safer alternative to other loan portfolios, especially amid the turbulence of global trade and the increasing value of real estate and real-estate development. Recently secured a partnership which appears to have expedited what was already anticipated last week in terms of Price Action . Have not yet read up on these developments (tend to not pay attention to news) but from what I hear, seems to have stirred up investor interest.
NASDAQ:LMFALong
by GregoryMichelson